NCT07007325View on ClinicalTrials.gov

Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

September 15, 2027

Study Completion Date

September 15, 2029

Conditions
Small Cell Lung Carcinoma (SCLC)
Interventions
DRUG

[68Ga]Ga-PentixaFor

\[68Ga\]Ga-PentixaFor PET-CT

Trial Locations (3)

44805

Institut de cancérologie de l'ouest, Saint-Herblain

49055

Institut de cancérologie de l'ouest, Angers

49100

CHU d'Angers, Angers

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT07007325 - Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression | Biotech Hunter | Biotech Hunter